Updates in High-Risk Myelodysplastic Syndromes (MDS) - Conversation 1 of 2
High-risk myelodysplastic syndromes (MDS) pose a challenge in terms of diagnosis, risk stratification, and treatment. Additionally, in recent years, the clinical, molecular, cellular, and immunological factors associated with high-risk MDS have become clearer.
This has led to several updates in the diagnosis and management of high-risk MDS, which will be discussed by Dr. Gail Roboz, Dr. Courtney DiNardo, and Dr. Rami Komrokji. The expert faculty will also review clinical case scenarios to guide participants in integrating recent updates in high-risk MDS.
Faculty:Courtney DiNardo, MD, MSCE, Rami Komrokji, MD and Gail Roboz, MD
Accreditation Type:Expired Activity
Launch Date:November 22, 2021
Release Date:November 18, 2021
Expiration Date: September 30, 2022
Estimated Time to Complete Activity:Expired Activity